Suppr超能文献

在清醒的啮齿动物中,氢溴酸盐和盐酸盐布普品的脑电图和行为惊厥效应。

Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents.

机构信息

Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.

出版信息

Neuropsychiatr Dis Treat. 2009;5:189-206. doi: 10.2147/ndt.s4714. Epub 2009 Apr 8.

Abstract

A novel bromide salt of the antidepressant bupropion (bupropion HBr) has recently been developed and approved for use in the United States. Given previous use of bromides to treat seizures, and that the existing chloride salt of bupropion (HCl) can cause seizures, it is important to determine if the HBr salt may be less likely to cause seizures than the HCl salt. In the present animal studies this was evaluated by means of quantified electroencephalogram (EEG), observation, and the rotarod test in mice and rats. Both bupropion salts were tested at increasing equimolar doses administered intraperitoneally. The results in mice showed that bupropion HCl 125 mg/kg induced a significantly higher ten-fold increase in the mean number of cortical EEG seizures compared to bupropion HBr (7.50 +/- 2.56 vs 0.75 +/- 0.96; p = 0.045), but neither drug caused any brain injuries. In rats bupropion HBr 100 mg/kg induced single EEG seizure activity in the cortical and hippocampal (depth) electrodes and in significantly (p < 0.05) fewer rats (44%) compared to bupropion HCl, which induced 1 to 4 convulsions per rat in all rats (100%) dosed. The total duration of cortical seizures in bupropion HCl-treated rats was significantly longer than the corresponding values obtained in bupropion HBr-treated rats (424.6 seconds vs 124.5 seconds respectively, p < 0.05). Bupropion HCl consistently induced more severe convulsions at each dose level compared to bupropion HBr. Both treatments demonstrated a similar dose-dependent impairment of rotarod performance in mice. In conclusion, these findings suggest that bupropion HBr may have a significantly lower potential to induce seizures in mice and rats, particularly at higher doses, compared to bupropion HCl. Determination of this potential clinical advantage will require human studies. If confirmed by such studies, it is likely that this potential beneficial clinical benefit would be due to the presence of the bromide salt given the long history of the use of bromide to treat seizure disorders.

摘要

一种新型抗抑郁药安非他酮的溴化物盐(安非他酮 HBr)最近已在美国开发并获准使用。鉴于先前使用溴化物治疗癫痫,并且现有的安非他酮氯化物(HCl)可引起癫痫发作,因此重要的是要确定 HBr 盐是否比 HCl 盐更不易引起癫痫发作。在目前的动物研究中,通过定量脑电图(EEG)、观察和旋转棒试验在小鼠和大鼠中进行了评估。两种安非他酮盐均以递增的等摩尔剂量经腹腔注射进行测试。在小鼠中的结果表明,安非他酮 HCl 125mg/kg 引起皮质 EEG 癫痫发作的平均数量增加了近 10 倍,明显高于安非他酮 HBr(7.50±2.56 对 0.75±0.96;p=0.045),但两种药物均未引起任何脑损伤。在大鼠中,安非他酮 HBr 100mg/kg 在皮质和海马(深度)电极中引起单个 EEG 癫痫发作活动,并且与安非他酮 HCl 相比,在明显较少的大鼠(44%)中引起发作,而安非他酮 HCl 在所有大鼠(100%)中引起 1 至 4 次癫痫发作。在安非他酮 HCl 治疗的大鼠中,皮质癫痫发作的总持续时间明显长于在安非他酮 HBr 治疗的大鼠中获得的相应值(分别为 424.6 秒和 124.5 秒,p<0.05)。与安非他酮 HBr 相比,安非他酮 HCl 始终在每个剂量水平上引起更严重的癫痫发作。两种治疗方法均在小鼠中表现出类似的剂量依赖性旋转棒性能障碍。总之,这些发现表明,与安非他酮 HCl 相比,安非他酮 HBr 在小鼠和大鼠中引起癫痫发作的潜力明显较低,特别是在较高剂量下。确定这种潜在的临床优势将需要进行人体研究。如果通过此类研究得到证实,那么这种潜在的有益的临床益处很可能是由于存在溴化物盐,因为溴化物治疗癫痫发作已有很长的历史。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77c/2695230/2619a1cde0e5/ndt-5-189f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验